Cargando…

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients

Analysis of the genotype that predicts the phenotypic characteristics of a cohort of glaucoma and ocular hypertension patients, and the correlation with their personal pharmacological response to beta-blockers (BB) and prostaglandin analogues (PGA). Prospective study that included 139 eyes from 72 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opazo-Toro, Valeria, Fortuna, Virginia, Jiménez, Wladimiro, Pazos López, Marta, Royo, María Jesús Muniesa, Ventura-Abreu, Néstor, Brunet, Mercè, Milla, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916755/ https://www.ncbi.nlm.nih.gov/pubmed/36768422 http://dx.doi.org/10.3390/ijms24032093

Ejemplares similares

Surgical Approach and Outcomes of Uveitic Glaucoma in a Tertiary Hospital
por: Ventura-Abreu, Nestor, et al.
Publicado: (2021)

Therapeutic conflict in patients with COVID-19 and glaucoma()
por: Millá Griñó, Elena, et al.
Publicado: (2020)

Differential Gene and Protein Expression of Conjunctival Bleb Hyperfibrosis in Early Failure of Glaucoma Surgery
por: Millá, Elena, et al.
Publicado: (2023)

Conflicto terapéutico en pacientes con COVID-19 y glaucoma
por: Millá Griñó, Elena, et al.
Publicado: (2020)

Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
por: Liu, Yuanzhi, et al.
Publicado: (2019)

New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
por: Alviset, Gabriel, et al.
Publicado: (2022)

Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

External Validation and Clinical Applicability of Two Optical Coherence Tomography–Based Risk Calculators for Detecting Glaucoma
por: Ventura-Abreu, Néstor, et al.
Publicado: (2022)

Topical Prostaglandin Analogues and Conjunctival Inflammation in Uveitic Glaucoma
por: Taylor, Simon RJ, et al.
Publicado: (2012)

Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
por: Shen, Wencui, et al.
Publicado: (2019)

Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019)

Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
por: Hu, Jason, et al.
Publicado: (2020)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)

Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
por: Ha, Jun Young, et al.
Publicado: (2019)

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Horsley, Michael B, et al.
Publicado: (2009)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
por: Frenkel, Ronald EP, et al.
Publicado: (2007)

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
por: Honrubia, F, et al.
Publicado: (2009)

Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
por: LOPES, Nara Lidia Vieira, et al.
Publicado: (2019)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Effects of aqueous suppressants and prostaglandin analogues on early wound healing after glaucoma implant surgery
por: Jung, Kyoung In, et al.
Publicado: (2019)

Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
por: Mancino, R, et al.
Publicado: (2018)

The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
por: Meda, Roman, et al.
Publicado: (2017)

Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
por: Park, Ji-Hye, et al.
Publicado: (2021)

Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
por: Wong, Tina T, et al.
Publicado: (2018)

Treatment of glaucoma by prostaglandin agonists and beta‐blockers in combination directly reduces pro‐fibrotic gene expression in trabecular meshwork
por: Tejwani, Sushma, et al.
Publicado: (2020)

Comparison of Intraocular Pressure, Blood Pressure, Ocular Perfusion Pressure and Blood Flow Fluctuations During Dorzolamide Versus Timolol Add-On Therapy in Prostaglandin Analogue Treated Glaucoma Subjects
por: Januleviciene, Ingrida, et al.
Publicado: (2012)

Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
por: Seong, Hyo Jin, et al.
Publicado: (2021)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
por: Yoshikawa, Keiji, et al.
Publicado: (2021)

A Cross-Sectional Survey of the Association between Bilateral Topical Prostaglandin Analogue Use and Ocular Adnexal Features
por: Shah, Mamta, et al.
Publicado: (2013)

Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
por: Milla, Elena, et al.
Publicado: (2017)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
por: Niwano, Yoshimi, et al.
Publicado: (2014)

Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
por: Takagi, Yasutaka, et al.
Publicado: (2018)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
por: Hommer, Anton, et al.
Publicado: (2015)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate, Ngamkae, et al.
Publicado: (2020)

Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
por: Kocabeyoglu, Sibel, et al.
Publicado: (2015)

Effect of prostaglandin analogues on central corneal thickness in patients with glaucoma: A systematic review and meta-analysis with trial sequential analysis
por: Kadri, Rajani, et al.
Publicado: (2022)

Topical Prostaglandin Analogue Drugs Inhibit Adipocyte Differentiation
por: Kim, Jae Woo
Publicado: (2014)

Contralateral intraocular pressure lowering effect of prostaglandin analogues
por: Rao, Harsha L., et al.
Publicado: (2014)

The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy
por: Choi, Catherine J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_urad5uje3dnumntobs16vr3ei4